Genetic PEGylation

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Tada, Seiichi ^a   Andou, Takashi ^a,b   Suzuki, Takehiro ^a   Dohmae, Naoshi ^a   Kobatake, Eiry ^b   Ito, Yoshihiro ^a,b  

^a RIKEN   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; MACROGOL; THIOREDOXIN; TRANSFER RNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DNA TEMPLATE; GENETIC TRANSCRIPTION AND TRANSLATION; IN VITRO STUDY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PROCESS OPTIMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RNA TRANSLATION; SEQUENCE ANALYSIS; STOP CODON; STRUCTURE ANALYSIS; TRANSLATION REGULATION; WESTERN BLOTTING;

ACYLATION; AMINO ACIDS; CODON, TERMINATOR; MASS SPECTROMETRY; MODELS, GENETIC; MOLECULAR WEIGHT; PEPTIDES; POLYETHYLENE GLYCOLS; PROTEIN BIOSYNTHESIS; PROTEIN ENGINEERING; RNA, TRANSFER;

EID: 84869047111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049235     Document Type: Article

References (52)

1. Ito Y, Sugimura N, Kwon OH, Imanishi Y, (1999) Enzyme modification by polymers with solubilities that change in response to photoirradiation in organic media. Nature Biotechnol 17: 73-75.
2. Kwon OH, Imanishi Y, Ito Y, (1999) Catalytic activity and conformation of chemically modified subtilisin Carlsberg in organic media. Biotechnol Bioeng 66: 265-270.
3. Pennadam S, Firman K, Alexander C, Gorecki D, (2004) Protein-polymer nano-machines. Towards synthetic control of biological processes. J Nanotechnol 2: 1-7.
4. Elvira C, Gallardo A, Roman JS, Cifuentes A, (2005) Covalent polymer-drug conjugates. Molecules 10: 114-125.
5. Hest JCM, (2007) Biosynthetic-synthetic polymer conjugates. J Macromol Sci Part C Polym Rev 47: 63-92.
6. Broyer RM, Grover GN, Maynard HD, (2011) Emerging synthetic approaches for protein-polymer conjugations, Chem Commun. 47: 2212-2226.
7. Klok H-A, (2009) Peptide/protein-polymer conjugates: Quo Vadis. Macromolecules 42: 7990-8000.
8. De Graaf AJ, Kooijiman M, Hennink WE, Mastrobattista E, (2009) Nonnatural amino acids for site-specific protein conjugation. Bioconjug Chem 20: 1281-1295.
9. Krishna OD, Kiick KL, (2010) Protein- and peptide-modified synthetic polymeric biomaterials. Biopolymers (Pep Sci) 94: 32-48.
10. Velonia K, (2010) Protein-polymer amphiphilic chimeras: recent advances and future challenges. Polym Chem 1: 944-952.
11. Veronese FM, Mero A, (2008) The impact of PEGylation on biological therapies. Biodrugs 22: 315-329.
12. Joralemon MJ, McRae S, Emrick T, (2010) PEGylated polymers for medicine: from conjugation to self-assembled systems. Chem Commun 46: 1377-1393.
13. Abuchowsky A, Van Es T, Palczuk NC, Davis FF, (1977) Alteration of immunological properties of bovine serum by covalent attachment of polyethylene glycol. J Biol Chem 251: 3578-3581.
14. Abuchowsky A, McCoy TJR, Palczuk NC, Van Es T, Davis FF, (1977) Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 251: 3578-3581.
15. Harris JM, Chess RB, (2003) Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discovery 2: 214-221.
16. Catillo B, Sola RJ, Ferrer A, Barletta G, Griebenow K, (2007) Effect of PEG modification on subtilisin Carsberg activity, enantioselectivity, and structural dynamics in 1,4-dioxane. Biotechnol Bioeng 99: 9-17.
17. Kinstler O, Molinewx G, Treuheit M, Ladd D, Gegg C, (2002) Mono-N-terminal poly(ethylene glycol)-protein conjugates. Adv Drug Del Rev 54: 477-485.
18. Yamamoto Y, Tsutsumi Y, Yoshioka Y, Nishibata T, Kobayashi K, et al. (2003) Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity. Nat Biotechnol 21: 546-552.
19. Wang JH, Tam SC, Huang H, Ouyang DY, Wang YY, et al. (2004) Site-directed PEGylation of trichostanthin retained its anti-HIV activity with reduced potency in vitro. Biochim Biophys Res Comm 3317: 965-971.
20. Doherty DH, Rosendahl MS, Smith DJ, Hughes JM, Chlipala EA, et al. (2005) Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor. Bioconjug Chem 16: 1291-1298.
21. Sato H, (2002) Enzymatic procedure for site-specific pegylation of proteins. Adv Drug Delivery 54: 487-504.
22. Kostiainen MA, Szilvay GR, Lehtinen J, Smith DK, Linder MB, et al. (2007) Precisely defined protein-polymer conjugates: Construction of synthetic DNA binding domains on proteins by using multivalent dendrons. ACS Nano 1: 103-113.
23. Wang H, He L, Lensch M, Gabius H-J, Fee CJ, et al. (2008) Single-site cys-substituting mutation of human lectin galectin-2: Modulating solubility in recombinant production, reducing long-term aggregation, and enabling site-specific monoPEGylation. Biomacromolecules. 9: 3223-3230.
24. Hu J, Duppatla V, Harth S, Schmitz W, Sebald W, (2010) Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues. Bioconjug Chem 21: 1762-1772.
25. Schumacher FF, Nobles M, Ryan CP, Smith MEB, Tinker A, et al. (2011) In situ maleimide bridging of disulfides and a new approach to protein PEGylation. Bioconjug Chem 22: 132-136.
26. Joshi NS, Whitaker LR, Francis MB, (2004) A three-component Mannich-type reaction for selective tyrosine bioconjugation. J Am Chem Soc 126: 15942-15943.
27. Tilley SD, Francis MB, (2006) Tyrosine-selective protein alkylation using p-palladium complexes. J Am Chem Soc 128: 1080-1081.
28. Cazalis CS, Haller CA, Sease-Cargo L, Chaikof EL, (2004) C-Terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. Bioconjug Chem 15: 1005-1009.
29. Cong Y, Pawlisz E, Bryant P, Balan S, Laurine E, et al. (2012) Site-specific PEGylation at histidine tags. Bioconjug Chem 23: 248-263.
30. Kochendoerfer GG, Chen SY, Mao F, Cressman S, Traviglia S, et al. (2003) Design and chemical synthesis of homogeneous polymer-modified erythropoiesis protein. Science 299: 884-887.
31. Chen SY, Cressman S, Mao F, Shao H, Low DW, et al. (2005) Synthetic erythropoietic proteins: tuning biological performance by site-specific polymer attachment. Chem Biol 12: 371-383.
32. Sletten EM, Bertozzi CR, (2009) Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew Chem Int Ed Engl 48: 6974-6998.
33. Kalia J, Raines T, (2010) Advances in bioconjugation. Curr Org Chem 14: 138-147.
34. Boyce M, Bertozzi CR, (2011) Bridging chemistry to life. Nat Meth 8: 638-642.
35. Berzozzi CR, (2011) Guest Editorial A decade of bioorthogonal chemistry. Acc Chem Res 44: 651-653.
36. Stephanopoulos N, Francis MB, (2011) Choosing an effective protein bioconjugation strategy. Nat Chem Biol 7: 876-884.
37. Noren CJ, Anthony-Cahill SJ, Griffith MC, Schultz PG, (1989) A general method for site-specific incorporation of unnatural amino acids into proteins. Science 244: 182-188.
38. Bain JD, Glabe CG, Dix TA, Chamberlin AR, Diala ES, (1989) Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide. J Am Chem Soc 111: 8013-8014.
39. Josephson K, Hartman MC, Szostak JW, (2005) Ribosomal synthesis of unnatural peptides. J Am Chem Soc 127: 11727-11735.
40. Wang L, Xie J, Schultz PG, (2006) Expanding the genetic code. Annu Rev Biophys Biomol Struct 35: 225-249.
41. Liu CC, Schultz PG, (2010) Adding new chemistries to the genetic code. Annu Rev Biochem 79: 413-444.
42. Young TS, Schults PG, (2010) Beyoud the canonical 20 amino acids: Expanding the genetic lexicon. J Biol Chem 285: 11039-11044.
43. Wang F, Robbins S, Guo J, Shen W, Schults PG, (2010) Genetic incorporation of unnatural amino acids into proteins in Mycobacterium tuberculosis. PLoS ONE 5: e9354.
44. Deiters A, Cropp TA, Summerer D, Mukherji M, Schultz PG, (2004) Site-specific PEGylation of proteins containing unnatural amino acids. Bioorg Med Chem Lett 14: 5743-5745.
45. Johnson DB, Xu J, Shen Z, Takimoto JK, Schultz MD, et al. (2011) RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites. Nat Chem Biol 7: 779-786.
46. Hohsaka T, Ashizuka Y, Murakami H, Sisido M, (1996) Incorporation of non-natural amino acids into streptavidin through in vitro frame-shift suppression. J Am Chem Soc 118: 9778-9779.
47. Shozen N, Iijima I, Hohsaka T, (2009) Site-specific incorporation of PEGylated amino acids into proteins using nonnatural amino acid mutagenesis. Bioorg Med Chem Lett 19: 4909-4911.
48. Hohsaka T, Kajihara D, Ashizuka Y, Murakami H, Sisido M, (1999) Efficient incorporation of nonnatural amino acids with large aromatic groups into streptavidin in in vitro protein synthesizing systems. J Am Chem Soc 121: 34-40.
49. Kajihara D, Abe R, Iijima I, Komiyama C, Sisido M, et al. (2006) FRET analysis of protein conformational change through position-specific incorporation of fluorescent amino acids. Nat Methods 3: 923-929.
50. Watanabe T, Muranaka N, Iijima I, Hohsaka T, (2007) Position-specific incorporation of biotinylated non-natural amino acids into a protein in a cell-free translation system. Biochem Biophys Res Commun 361: 794-799.
51. Abe R, Shiraga K, Ebisu S, Takagi H, Hohsaka T, (2010) Incorporation of fluorescent non-natural amino acids into N-terminal tag of proteins in cell-free translation and dependence of position and neighboring codons. J Biosci Bioeng 110: 32-38.
52. Bundy BC, Swartz JR, (2010) Site-specific incorporation of p-propargyloxyphenylalanine in a cell-free environment for direct protein-protein click conjugation. Bioconjug Chem 21: 255-263.